150 related articles for article (PubMed ID: 31066955)
1. Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
Saba KH; Cornmark L; Rissler M; Fioretos T; Åström K; Haglund F; Rosenberg AE; Brosjö O; Nord KH
Genes Chromosomes Cancer; 2019 Oct; 58(10):731-736. PubMed ID: 31066955
[TBL] [Abstract][Full Text] [Related]
2. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.
Lee JC; Su SY; Changou CA; Yang RS; Tsai KS; Collins MT; Orwoll ES; Lin CY; Chen SH; Shih SR; Lee CH; Oda Y; Billings SD; Li CF; Nielsen GP; Konishi E; Petersson F; Carpenter TO; Sittampalam K; Huang HY; Folpe AL
Mod Pathol; 2016 Nov; 29(11):1335-1346. PubMed ID: 27443518
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
Papke DJ; Hung YP; Schaefer IM; Bredella MA; Charville GW; Reith JD; Fletcher CDM; Nielsen GP; Hornick JL
Mod Pathol; 2020 Nov; 33(11):2295-2306. PubMed ID: 32601382
[TBL] [Abstract][Full Text] [Related]
4. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.
Lee JC; Jeng YM; Su SY; Wu CT; Tsai KS; Lee CH; Lin CY; Carter JM; Huang JW; Chen SH; Shih SR; Mariño-Enríquez A; Chen CC; Folpe AL; Chang YL; Liang CW
J Pathol; 2015 Mar; 235(4):539-45. PubMed ID: 25319834
[TBL] [Abstract][Full Text] [Related]
6. Chondroblastoma: An Update.
Chen W; DiFrancesco LM
Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
[TBL] [Abstract][Full Text] [Related]
7. From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses.
Mok Y; Lee JC; Lum JH; Petersson F
Histopathology; 2016 May; 68(6):925-30. PubMed ID: 26407099
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
[TBL] [Abstract][Full Text] [Related]
9. Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.
Gaeta R; Righi A; Gambarotti M; Aretini P; Lessi F; Mazzanti CM; Mancini I; Pinzani P; Belgio B; Sbaraglia M; Tos APD; Franchi A
Histopathology; 2022 Sep; 81(3):389-401. PubMed ID: 35791778
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic lockdown of CDKN1A (p21) and CDKN2A (p16) characterises the neoplastic spindle cell component of giant cell tumours of bone.
Giesche J; Mellert K; Geißler S; Arndt S; Seeling C; von Baer A; Schultheiss M; Marienfeld R; Möller P; Barth TF
J Pathol; 2022 Aug; 257(5):687-696. PubMed ID: 35522566
[TBL] [Abstract][Full Text] [Related]
11. Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis.
Liu YJ; Wang W; Yeh J; Wu Y; Mantilla JG; Fletcher CDM; Ricciotti RW; Chen EY
Mod Pathol; 2021 Jul; 34(7):1373-1383. PubMed ID: 33727696
[TBL] [Abstract][Full Text] [Related]
12. Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma.
Mohseny AB; Tieken C; van der Velden PA; Szuhai K; de Andrea C; Hogendoorn PC; Cleton-Jansen AM
Genes Chromosomes Cancer; 2010 Dec; 49(12):1095-103. PubMed ID: 20737480
[TBL] [Abstract][Full Text] [Related]
13. Phosphaturic mesenchymal tumors: A review and update.
Folpe AL
Semin Diagn Pathol; 2019 Jul; 36(4):260-268. PubMed ID: 31301876
[TBL] [Abstract][Full Text] [Related]
14. Klotho Overexpression Is Frequently Associated With Upstream Rearrangements in Fusion-Negative Phosphaturic Mesenchymal Tumors of Bone and Sinonasal Tract.
Lee JC; Hsieh TH; Kao YC; Tsai CF; Huang HY; Shih CY; Song HL; Oda Y; Chih-Hsueh Chen P; Pan CC; Sittampalam K; Petersson F; Konishi E; Chiu WY; Chen CF; Carpenter TO; Lu TP; Chang CD; Huang SC; Folpe AL
Mod Pathol; 2023 Dec; 36(12):100336. PubMed ID: 37742927
[TBL] [Abstract][Full Text] [Related]
15. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
Amary F; Perez-Casanova L; Ye H; Cottone L; Strobl AC; Cool P; Miranda E; Berisha F; Aston W; Rocha M; O'Donnell P; Pillay N; Tirabosco R; Baumhoer D; Hookway ES; Flanagan AM
Mod Pathol; 2019 Dec; 32(12):1762-1771. PubMed ID: 31273315
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
[TBL] [Abstract][Full Text] [Related]
17. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.
Bahrami A; Weiss SW; Montgomery E; Horvai AE; Jin L; Inwards CY; Folpe AL
Am J Surg Pathol; 2009 Sep; 33(9):1348-54. PubMed ID: 19609206
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors.
Tajima S; Fukayama M
Int J Clin Exp Pathol; 2015; 8(8):9422-7. PubMed ID: 26464698
[TBL] [Abstract][Full Text] [Related]
19. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Baumhoer D; Amary F; Flanagan AM
Genes Chromosomes Cancer; 2019 Feb; 58(2):88-99. PubMed ID: 30582658
[TBL] [Abstract][Full Text] [Related]
20. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
